17 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Apoetm1Unc/Apoetm1Unc Itgb3tm1Hyn/Itgb3tm1Hyn involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6	anemia	J:83615
	atherosclerotic lesions	J:83615
	decreased susceptibility to diet-induced obesity	J:83615
	increased susceptibility to induced morbidity/mortality	J:83615
	lung inflammation	J:83615
	postnatal lethality, incomplete penetrance	J:83615
	premature death	J:83615
Fbn1tm2.1Hcd/Fbn1+ Itgb3tm1Hyn/Itgb3+ involves: 129S * 129X1/SvJ * C57BL/6J * FVB/N	abnormal cutaneous collagen fibril morphology	J:206074
	epidermal hyperplasia	J:206074
	normal integument phenotype	J:206074
	thick dermal layer	J:206074
Fbn1tm3.1Hcd/Fbn1+ Itgb3tm1Hyn/Itgb3+ involves: 129S * 129X1/SvJ * C57BL/6J * FVB/N	abnormal cutaneous collagen fibril morphology	J:206074
	epidermal hyperplasia	J:206074
	normal integument phenotype	J:206074
	thick dermal layer	J:206074
Ilktm2Star/Ilk+ Itgb3tm1Hyn/Itgb3+ involves: 129S2/SvPas * C57BL/6	increased trabecular bone thickness	J:197593
Itgb3tm1Hyn/Itgb3tm1Hyn Itgb5tm1Des/Itgb5tm1Des involves: 129S2/SvPas * 129S4/SvJae * C57BL/6	abnormal tumor vascularization	J:73752
	increased tumor growth/size	J:73752
Itgb3tm1Hyn/Itgb3tm1Hyn Ldlrtm1Her/Ldlrtm1Her involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6	atherosclerotic lesions	J:83615
	decreased circulating cholesterol level	J:83615
	decreased survivor rate	J:83615
	increased circulating glucose level	J:83615
	increased susceptibility to induced morbidity/mortality	J:83615